Sergio Traversa, CEO at RELMADA THERAPEUTICS, INC. (RLMD), sold 6,456 shares at $35.08 ($226K) on 2021-02-02, disclosed to the SEC on 2021-02-04.
Open-market sale of $226k RLMD by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.08 | 3,178 | $111K | 49.2% |
| 2 | $35.08 | 3,178 | $111K | 49.2% |
| 3 | $35.00 | 100 | $4K | 1.5% |
| Total | $35.08 avg | 6,456 | $226K | 100% |
| Filing → |
| RLMD | BUY | 2025-11-06 | $600K | — | Filing → |
| RLMD | BUY | 2025-08-28 | $265K | — | Filing → |
| RLMD | BUY | 2025-05-20 | $335K | — | Filing → |